repaired or not, does not preclude patients from holding an ordinary driving licence." Possibly this statement should be extended to include suggestions relating to screening of patients of the relevant age group and sex to identify such high risk disease.
Conclusions
In this study there was no evidence to suggest that sudden natural death in road users, mainly from cardiovascular disease, represents a substantial threat to other road users. It is reasonable to presume that the number of road users will continue to increase, including the number of elderly road users in all categories. As yet there is no evidence of any appreciable drop in the 50% mortality from coronary heart disease, and there certainly appears to be no justification for restricting or depriving that group of patients of driving licences because of their pre-existing cardiac condition. The group represented by the men who collapsed and died suddenly on the road from ruptured undiagnosed abdominal aortic aneurysms should be a cause for concern. It would be economically unacceptable and inappropriate to institute routine medical examinations for all drivers over a certain age to rule out the possibility of cardiac conditions that are still responsible for the vast majority of natural deaths on the road. In relation to these conditions the recommendations in the handbook dealing with medical fitness to drive' appear to be valid, appropriate, and sensible. Forty one patients ovulated and 27 conceived, but nine pregnancies terminated within four weeks after ovulation. Basal luteinising hormone concentrations were significantly lower in those who conceived (range 1-3-29-0) IU/l) than in those who did not (19-0 (3.5-50-0) IU/l) and in those whose pregnancy progressed (9.6 (1.3-29-0) IU/l) than in those with early loss of pregnancy (17-9 (7.0-29.0) IU/l). Concentrations at the time of maximum foilicular growth were significantly lower in women who ovulated (9.4 (2-9-35.4) IU/l) than in those who did not (29-0 (7.0-50.0) IU/l) and in those who conceived (6-2 (2-9-8-5) IU/l) than in those who did not (17-9 (4-0-50.0) IU/l).
These results indicate that high concentrations of luteinising hormone during the follicular phase in women with polycystic ovaries have a deleterious effect on rates of conception and may be a causal factor in early pregnancy loss.
Introduction
Infertile *p=0O02, **p=0-01, ***p=0o003.
to outcome (early loss or delivery (including the two late abortions)). 
Discussion
The rate of ovulation (54% of cycles, 76% of patients), the cumulative rate of conception at six months (50%), and the rate of early pregnancy loss (33%) in the 54 patients studied were all disappointing when compared with the results of the same treatment in patients with hypogonadotrophic hypogonadism.'
In women with the polycystic ovary syndrome obesity and hyperandrogenism are adverse factors for induction of ovulation with luteinising hormone releasing hormone,4 but the present study indicates that raised basal serum luteinising hormone concentrations and, more specifically, raised luteinising hormone concentrations at the time of maximum follicular growth significantly interfere with conception and may be a causal factor in early pregnancy loss. Exposure of the ovaries to high concentrations of luteinising hormone during the phase of follicular growth thus seems to be deleterious to the developing oocyte.7 Because, however, we measured luteinising hormone at the time of maximum follicular growth in only four patients who did not ovulate, the significant difference in concentrations between patients who did and did not ovulate (table II) must be interpreted with caution.
In the normal ovulatory cycle the oocyte is fully mature 36-48 hours before ovulation, and timely maturation is a prerequisite for successful fertilisation and development of the embryo. Up to this time the progress of meiosis is thought to be inhibited by a factor that is itself inhibited by the action of luteinising hormone at mid-cycle, so ensuring ovulation of an egg matured at the appropriate time. 89 We hypothesise BMJ VOLUME 297 that when concentrations of luteinising hormone are high throughout the follicular phase, as in some women with polycystic ovaries, the hormone penetrates the follicle and allows the oocyte to mature prematurely, resulting in ovulation of an oocyte that is physiologically "aged." Such oocytes are unlikely to be fertilised or will tend to produce embryos that implant poorly and therefore abort. Data that support this model were reported in studies of pigs in which premature ovulation (and presumably maturation of oocytes) was induced with human chorionic gonadotrophin'°and in studies of rats in which insemination was delayed." In both studies the interval between maturation of the oocytes and fertilisation was extended and rates of fertilisation and embryo survival were impaired. In women extension of the interval between ovulation and insemination was associated with a striking increase in the rate of miscarriage.'2 Moreover, Stanger and Yovitch, Howles et al, and Punnonen et al have reported that high concentrations of luteinising hormone in the few days before oocytes were collected from women for in vitro fertilisation were associated with impaired rates of fertilisation and conception.
Our results show that high concentrations of luteinising hormone during the follicular phase, found in many women with the polycystic ovary syndrome, have a deleterious effect on the success of induction of ovulation and conception and may be a causal factor in early pregnancy loss. As recent studies suggest that the polycystic ovary syndrome is common, both in patients attending infertility clinics and in the general population,"6 " many patients may perhaps experience early miscarriage because of an endocrine disturbance. A potential treatment for these patients is to induce ovulation with exogenous gonadotrophins after desensitisation of the pituitary with a superactive analogue of luteinising hormone releasing hormone. 7 Absence of end diastolic frequencies in umbilical artery: a sign of fetal hypoxia and acidosis K H Nicolaides, C M Bilardo, P W Soothill, S Campbell
One of the main challenges of antenatal management is distinguishing between normal small fetuses and growth retarded fetuses, which are at increased risk of intrauterine death or asphyxia at birth. Cordocentesis and analysis of fetal blood gases have shown that some fetuses that are small for gestational age are chronically hypoxic and acidotic.' 2 Cordocentesis, however, is an invasive procedure and not widely available. In hypoxic fetuses the blood velocity in the aorta is decreased.3 Doppler measurement ofblood velocity is non-invasive but requires expensive pulsed Doppler equipment and an experienced operator. The presence or absence of end diastolic frequencies in the umbilical artery can be ascertained with continuous wave Doppler equipment, which is much cheaper and requires less training of the operator. We examined the relation of the oxygen tension and pH in fetal blood with the absence of end diastolic frequencies in flow velocity waveforms of the umbilical artery.
Methods and results
We studied the fetuses of 59 healthy pregnant women who had been referred from other units for investigation of fetal growth retardation. The fetuses were of 21-36 weeks' gestation and had an abdominal circumference below the fifth centile of our normal range. Blood flow velocity waveforms for the umbilical artery were obtained with continuous wave Doppler ultrasound and analysed by a spectrum analyser (Doptek Spectrascan analyser 9000, Doptek, Chichester). A 100 Hz filter was used to eliminate the low frequencies obtained from movements of the arterial wall. With the mother semirecumbent and the fetus apnoeic, the Doppler probe was moved over the uterus until the umbilical cord waveform was identified 
